R Scott Huennekens
CIK 1365493 · President & Chief Executive Of · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.22M
Companies
11
Total Filings
150
Lifetime Open-Market Net
-$30.96M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NPCE | Director | 2,890 | $15.64 | $45.2K | $0 | 3 | 2026-06-05 |
| QDEL | Director | 9,352 | $14.13 | $132.1K | $0 | 3 | 2026-06-02 |
| NVST | Director | 82,105 | $24.60 | $2.02M | $0 | 7 | 2026-05-21 |
| QSIAW | Director | — | $0.01 | — | $0 | 3 | 2024-06-12 |
| NUVASIVE INC (NUVA) Delisted | Director | 0 | $39.75 | $0 | $0 | 7 | 2023-09-05 |
| Acutus Medical, Inc. (AFIB) Delisted | Director | 529,349 | $0.09 | $47.6K | -$34.8K | 4 | 2023-06-15 |
| HYPR | Director | 19,586 | $1.36 | $26.6K | $0 | 4 | 2022-06-13 |
| ViewRay, Inc. (VRAY) Delisted | Director | 99,670 | $0.03 | $2.5K | $0 | 7 | 2020-06-17 |
| EndoChoice Holdings, Inc. (GI) Delisted | Director | 0 | — | — | $0 | 3 | 2016-11-23 |
| Bellerophon Therapeutics, Inc. (BLPH) Delisted | Director | — | $0.01 | — | $0 | 1 | 2015-05-14 |
| Volcano Corp (VOLC) Delisted | President & Chief Executive Of | 182,570 | — | — | -$30.93M | 104 | 2015-01-05 |
Recent Filings · Page 3 of 15
150 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-31 | NVST | Grant (A) | +5,930 | $0 | EDGAR |
| 2022-05-13 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-31 | HYPR | Grant (A) | — | $0 | EDGAR |
| 2022-01-10 | HYPR | Grant (A) | +19,586 | $0 | EDGAR |
| 2021-12-23 | HYPR | Grant (A) | +16,483 | $0 | EDGAR |
| 2021-05-27 | NVST | Grant (A) | +5,455 | $0 | EDGAR |
| 2021-05-20 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-17 | ViewRay, Inc. (VRAY) Delisted | Grant (A) | +52,752 | $0 | EDGAR |
| 2020-05-29 | NVST | Grant (A) | — | $0 | EDGAR |
| 2020-05-29 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.